NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD
TTM (2024-6-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 3.60M | 7.37M | 14.97M | 8.80M | 480.38K | |||
Research and Development | 3.12M | 5.00M | 12.18M | 6.31M | 193.55K | |||
Selling, General, and Administrative Expenses | 1.69M | 2.29M | 2.79M | 2.47M | 281.26K | |||
Operating Income | -3.60M | -7.37M | -14.97M | -8.80M | -480.38K | |||
Interest Income/Expense | 41.61K | -5.56K | 9.98K | 154.10K | N/A | |||
Non Recurring Items | N/A | 0.00 | -2.00K | N/A | N/A | |||
Income Before Taxes | -3.56M | -7.37M | -14.96M | -8.65M | -480.38K | |||
Net Income | -3.56M | -7.37M | -14.96M | -8.65M | -480.38K | |||
EBITDA | -3.53M | -7.29M | -14.97M | N/A | N/A | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.92 | -1.98 | -6.06 | -4.82 | -0.38 | |||
Statistics |
All data in CAD